Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 69.90
-0.61 (-0.87%)
Jul 10, 2026, 3:29 PM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 2.07 billion as of July 10, 2026. Its market cap has decreased by -45.73% in one year.
Market Cap
2.07B
Enterprise Value
2.08B
Revenue
857.38M
Ranking
n/a
PE Ratio
8.44
Stock Price
69.90
Market Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 2.07B, an increase of 1,872.18%. That is a compound annual growth rate of 22.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 2.07B | -12.10% |
| Dec 31, 2025 | 2.36B | -50.07% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.63B |
| Sigachi Industries | 8.66B |
| Bafna Pharmaceuticals | 4.84B |
| Valiant Laboratories | 3.37B |
| Nectar Lifesciences | 2.17B |
| Alpa Laboratories | 1.44B |
| Balaxi Pharmaceuticals | 1.33B |
| Par Drugs and Chemicals | 1.10B |